风湿性多肌痛与巨细胞动脉炎患者主动脉瘤、夹层或破裂的发生率
基于美国TriNetX数据库的回顾性队列研究显示,每1000人年中主动脉并发症发生率巨细胞动脉炎为11.69、风湿性多肌痛为6.78、一般人群为5.09;与风湿性多肌痛相比,巨细胞动脉炎发生任何主动脉并发症的风险更高(aHR 1.87,95%CI 1.58-2.21),一般人群风险相似(aHR 0.95,95%CI 0.84-1.06)。作者认为这些结果不支持对无巨细胞动脉炎特征的风湿性多肌痛患者筛查主动脉炎症。
要点
- 巨细胞动脉炎主动脉并发症发生率11.69/1000人年,高于风湿性多肌痛6.78/1000人年与一般人群5.09/1000人年。
- 与风湿性多肌痛相比,巨细胞动脉炎主动脉并发症风险aHR 1.87(95%CI 1.58-2.21)。
- 作者认为结果不支持对无巨细胞动脉炎特征的风湿性多肌痛患者筛查主动脉炎症。
核心结论
- 风湿性多肌痛患者大血管并发症风险与一般人群相似,且低于巨细胞动脉炎患者。
- 作者认为这些结果不支持对无巨细胞动脉炎特征的风湿性多肌痛患者筛查主动脉炎症。
研究设计与样本
- 基于美国TriNetX数据库(2000-2024年)的回顾性队列研究,通过≥2个ICD-9/ICD-10-CM诊断代码且同时接受糖皮质激素治疗识别风湿性多肌痛和巨细胞动脉炎患者。
- 匹配一般人群对照,比例为1:3。
- 共57,336例患者,其中风湿性多肌痛17,327例、巨细胞动脉炎4,734例、匹配对照35,275例。
- 中位随访时间3.74年(四分位距1.8-6.4)。
- 主要结局为主动脉并发症,定义为主动脉瘤与夹层/破裂的复合终点;采用Cox比例原因别风险模型计算校正风险比(aHR),以风湿性多肌痛为参照组。
主要发现
- 每1000人年任何主动脉并发症发生率:巨细胞动脉炎11.69,风湿性多肌痛6.78,一般人群5.09。
- 与风湿性多肌痛相比,巨细胞动脉炎发生任何主动脉并发症的风险更高(aHR 1.87,95%CI 1.58-2.21)。
- 与风湿性多肌痛相比,一般人群风险相似(aHR 0.95,95%CI 0.84-1.06)。
- 敏感性分析中, later发展为巨细胞动脉炎的风湿性多肌痛患者风险与初诊即为巨细胞动脉炎者相似(aHR 0.85,95%CI 0.60-1.19)。
临床怎么用
- 作者认为这些结果不支持对无巨细胞动脉炎特征的风湿性多肌痛患者筛查主动脉炎症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with polymyalgia rheumatica (PMR) may have subclinical large vessel vasculitis. We compared the incidence of aortic complications in PMR and giant cell arteritis (GCA) to the general population. METHODS: A retrospective cohort study was performed of patients with PMR and GCA identified by ≥2 ICD-9/ICD-10-CM diagnostic codes and concurrent corticosteroid treatment in the US-based TriNetX database (2000-2024). Matched general population controls were identified (1:3 ratio). The primary outcome, aortic complications, was a composite of aortic aneurysm and dissection/rupture. Adjusted hazard ratios (aHR) were calculated using Cox proportional cause-specific hazard models with PMR as the referent category. FINDINGS: Of 57,336 patients, 17,327 had PMR, 4,734 had GCA, and 35,275 were matched controls. Median follow-up time was 3.74 years (interquartile range, 1.8-6.4). The incidence rate of any aortic complication per 1,000 person-years was highest for GCA (11.69), followed by PMR (6.78) and the general population (5.09). Compared to patients with PMR, patients with GCA had a higher risk of any aortic complication (aHR 1.87, 95 % confidence interval (CI) 1.58-2.21); the general population risk was similar (aHR 0.95, 95 % CI 0.84-1.06). In a sensitivity analysis, patients with PMR who later developed GCA had a risk similar to those initially diagnosed with GCA (aHR 0.85, 95 % CI 0.60-1.19). INTERPRETATION: Patients with PMR had a similar risk of large vessel complications compared to the general population and a lower risk compared to those with GCA. These results do not support screening for aortic inflammation among patients with PMR who lack features of GCA.
引用
- Carlson K, Kaymakci M, Sattui SE, et al. Incidence of aortic aneurysm, dissection, or rupture among patients with polymyalgia rheumatica and giant cell arteritis. Semin Arthritis Rheum. 2025. PMID: 40127549. doi:10.1016/j.semarthrit.2025.152714
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。